Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilities-Reference-Cited by-同舟云学术

Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilities

Published:2019-06 Issue:6 Volume:21 Page:778-790
ISSN:1465-7392
Container-title:Nature Cell Biology
language:en
Short-container-title:Nat Cell Biol

Author:

Coppé Jean-Philippe^ORCID,Mori Miki,Pan Bo,Yau Christina,Wolf Denise M.,Ruiz-Saenz Ana^ORCID,Brunen Diede,Prahallad Anirudh,Cornelissen-Steijger Paulien,Kemper Kristel,Posch Christian^ORCID,Wang Changjun,Dreyer Courtney A.,Krijgsman Oscar,Lee Pei Rong Evelyn,Chen Zhongzhong,Peeper Daniel S.,Moasser Mark M.^ORCID,Bernards René^ORCID,van ‘t Veer Laura J.

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology

Link

http://www.nature.com/articles/s41556-019-0328-z.pdf

Reference70 articles.

1. Petricoin, E. F., Zoon, K. C., Kohn, E. C., Barrett, J. C. & Liotta, L. A. Clinical proteomics: translating benchside promise into bedside reality. Nat. Rev. Drug Discov. 1, 683–695 (2002).

2. Blume-Jensen, P. & Hunter, T. Oncogenic kinase signalling. Nature 411, 355–365 (2001).

3. Fleuren, E. D., Zhang, L., Wu, J. & Daly, R. J. The kinome ‘at large’ in cancer. Nat. Rev. Cancer 16, 83–98 (2016).

4. Johnson, S. A. & Hunter, T. Kinomics: methods for deciphering the kinome. Nat. Methods 2, 17–25 (2005).

5. Krogan, N. J., Lippman, S., Agard, D. A., Ashworth, A. & Ideker, T. The Cancer Cell Map Initiative: defining the hallmark networks of cancer. Mol. Cell 58, 690–698 (2015).

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Susceptibility and Treatment Challenges in Melanoma;Cells;2024-08-20

2. Targeting Smurf1 to block PDK1–Akt signaling in KRAS-mutated colorectal cancer;Nature Chemical Biology;2024-07-22

3. A comprehensive overview of the molecular features and therapeutic targets in BRAF^V600E‐mutant colorectal cancer;Clinical and Translational Medicine;2024-07

4. A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC;Cancer Research Communications;2024-07-01

5. Network-based elucidation of colon cancer drug resistance mechanisms by phosphoproteomic time-series analysis;Nature Communications;2024-05-09